Reliance Power announced the appointment of R Ashok as an Additional Director of the company with effect from 22 April 2022
Mangal Credit Fincorp will hold a meeting of the Board of Directors of the Company on 2 May 2022
Religare Enterprises announced that the Securities and Exchange Board of India SEBI has approved the companys application for settlement under the SEBI Settlement Proceedings Regulations 2018 without admission or denial of SEBIs findings for a payment of Rs 541 crore The company has accordingly deposited the suggested amount with SEBI and closed the legacy issues
Skyline Millars will hold a meeting of the Board of Directors of the Company on 12 May 2022
Alembic Pharmaceuticals Alembic today announced that its wholly owned subsidiary Aleor Dermaceuticals Aleor has received final approval from the US Food Drug Administration USFDA for its Abbreviated New Drug Application ANDA for Clobetasol Propionate Foam 005Percentage The approved ANDA is therapeutically equivalent to the reference listed drug product RLD Olux Foam 005Percentage of Mylan Pharmaceuticals Inc Clobetasol Propionate Foam is a corticosteroid indicated for treatment […]
The Board of ICICI Bank at its meeting held on 23 April 2022 has approved the appointment of Rakesh Jha DIN 00042075 as a Wholetime Director designated as Executive Director of the Bank subject to regulatory approvals for a period of five years effective from 01 May 2022 The Board also accepted the resignation of Vishakha Mulye Executive Director DIN 00203578 with effect from 31 […]
Zydus Lifesciences announced the publication of two manuscripts detailing the DREAM-ND and DREAM-D Phase 3 study results of Desidustat a novel HIF-PH inhibitor in the prestigious American Journal of Nephrology Desidustats development is based on the Nobel Prize in Medicine winning science on discoveries of the oxygen sensing mechanism of cells through hypoxia-inducible factor HIF Desidustat works by stabilizing the HIF complex and stimulating endogenous […]
Suven Pharmaceuticals has received upgrade in credit ratings for bank facilities from CRISIL as under Long term bank facilities – CRISIL A Stable upgraded from CRISIL A Stable Short term bank facilities – CRISIL A1 upgraded from CRISIL A1
Power Instrumentation Gujarat will hold a meeting of the Board of Directors of the Company on 30 April 2022
Torrent Power has entered into a Share Purchase Agreement SPA with SkyPower Southeast Asia III Investments and SkyPower Southeast Asia Holdings 2 the Sellers for the acquisition of 100Percentage securities of Sunshakti Solar Power Projects SPV The SPV operates 50 MW Solar Power Project in the state of Telangana Long-term Power Purchase Agreement PPA for the Project is with Northern Power Distribution Company of Telangana […]

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.